Asset One Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Asset One Wealth Management's BMY Position: Q1 2026 in Review
Asset One Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 2.7% in Q1 2026, buying an estimated $114K and bringing the position to 74,866 shares worth $4.45M. The position accounts for 0.49% of the portfolio, ranked #52.
Asset One Wealth Management first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Asset One Wealth Management held 74,866 shares of Bristol-Myers Squibb worth $4.45M as of Q1 2026.
- Asset One Wealth Management bought 1,954 Bristol-Myers Squibb shares in Q1 2026, an estimated $114K.
- Bristol-Myers Squibb made up 0.49% of Asset One Wealth Management's portfolio in Q1 2026, its #52 holding.
- Asset One Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Asset One Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.